Function of natural killer cells in immune defence against human leukemia

Autor: A Wodnar-Filipowicz, CP Kalberer

Publikováno v: Swiss Medical Weekly, Vol 136, Iss 2324 (2006)

Externí odkaz: https://doaj.org/article/1fbc7c5b2e8441bd9b088e977a292039

Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma.

Autor: Tschan-Plessl A; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland. Electronic address: astrid.tschan-plessl@usb.ch., Kalberer CP; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Wieboldt R; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Stern M; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Siegler U; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Wodnar-Filipowicz A; Stem Cell Center of Competence, University Basel, Basel, Switzerland., Gerull S; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Halter J; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Heim D; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Tichelli A; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Tsakiris DA; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Malmberg KJ; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway; Department of Medicine, Huddinge, Center for Infectious Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden., Passweg JR; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland., Bottos A; Clinical and Diagnostic Hematology, University Hospital Basel, Basel, Switzerland.

Publikováno v: Cytotherapy [Cytotherapy] 2021 Apr; Vol. 23 (4), pp. 329-338. Date of Electronic Publication: 2020 Nov 29.

Post-transcriptional regulation of ULBP1 ligand for the activating immunoreceptor NKG2D involves 3' untranslated region.

Autor: Himmelreich H; Experimental Hematology, Department of Biomedicine, University Hospital, Basel, Switzerland., Mathys A, Wodnar-Filipowicz A, Kalberer CP

Publikováno v: Human immunology [Hum Immunol] 2011 Jun; Vol. 72 (6), pp. 470-8. Date of Electronic Publication: 2011 Mar 13.

Human acute myeloid leukemia CD34+CD38- stem cells are susceptible to allorecognition and lysis by single KIR-expressing natural killer cells.

Autor: Langenkamp U; Experimental Hematology, Department of Biomedicine, University Hospital Basel, Basel, Switzerland., Siegler U, Jörger S, Diermayr S, Gratwohl A, Kalberer CP, Wodnar-Filipowicz A

Publikováno v: Haematologica [Haematologica] 2009 Nov; Vol. 94 (11), pp. 1590-4. Date of Electronic Publication: 2009 Jul 16.

Clinical stem-cell sources contain CD8+CD3+ T-cell receptor-negative cells that facilitate bone marrow repopulation with hematopoietic stem cells.

Autor: Bridenbaugh S; Experimental Hematology, Department of Research, University Hospital Basel, Basel, Switzerland., Kenins L, Bouliong-Pillai E, Kalberer CP, Shklovskaya E, Gratwohl A, Wodnar-Filipowicz A

Publikováno v: Blood [Blood] 2008 Feb 01; Vol. 111 (3), pp. 1735-8. Date of Electronic Publication: 2007 Nov 05.